The most advanced example of this is a recent study correcting the CD40 ligand gene (CD40LG), which has deactivating mutations in X‐linked hyper‐IgM syndrome type I (HIGM1) (Schiroli et al., 2019). Here, CD40LG is linked to X-linked hyper-IgM syndrome.